Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

MRNAARGX

Area by area

Overall Quant Score

How does it look overall? (out of 100)

MRNA

38/100

ARGX

80/100

Quality

Is it a profitable, well-run business?

MRNA

2.0/10

ARGX

8.2/10

Growth

Is the company growing?

MRNA

1.6/10

ARGX

10.0/10

Valuation

Is the price reasonable? (higher = cheaper)

MRNA

0.0/10

ARGX

4.1/10

Risk

How risky are the shares? (higher = lower risk)

MRNA

5.3/10

ARGX

7.7/10

Momentum

Is the share price trending up?

MRNA

9.6/10

ARGX

7.5/10

Financial strength

Is the balance sheet healthy?

MRNA

5.7/10

ARGX

9.0/10

The balanced view

Model-generated

Moderna, Inc.

This company scores below average, with a positive price trend, although its current valuation deserves attention.

Leads on: momentum

Best feature: positive price trend (Trend alignment (50/200 SMA): 3/3)

Watch out: valuation may be demanding (P/E (TTM): -28.4x)

argenx SE

This company scores well across most areas, with solid growth and supportive analyst views, although its current valuation deserves attention.

Leads on: quality, growth, valuation, risk, financial strength

Best feature: solid growth (Revenue growth (FY): 89.6%)

Watch out: valuation may be demanding (DCF upside: -668.4%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.